drugset / Trial / NCT05150704

Summary

This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).

Timeline

Start
2021-10-07
Primary completion
2028-03
Completion
2028-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 1 g Intravenous

Indications